Abstract
Molecular and genetic breakthroughs continue to amplify our knowledge of the limb-girdle muscular dystrophies. Despite a common, basic phenotype, the myriad of genes underlying these genetic muscle diseases bring about substantial heterogeneity in pathogenesis and clinical course. Distinctive clinical, laboratory and biopsy features often help distinguish amongst them. Treatment, previously predominantly supportive, is transforming toward disease modifying, gene-based therapins.
| Original language | English (US) |
|---|---|
| Title of host publication | The Curated Reference Collection in Neuroscience and Biobehavioral Psychology |
| Publisher | Elsevier Science Ltd. |
| Pages | 890-896 |
| Number of pages | 7 |
| ISBN (Electronic) | 9780128093245 |
| DOIs | |
| State | Published - Jan 1 2016 |
| Externally published | Yes |
Keywords
- Alpha-dystroglycan
- Anoctamin
- Calpain
- Caveolin
- Creatine kinase
- Dysferlin
- Fukutin-related protein
- Lamin A/C
- Limb-girdle muscular dystrophy
- Muscle biopsy
- Sarcoglycan
- Telethonin
- Titin
- Valosin containing protein
ASJC Scopus subject areas
- General Medicine